Innovent Receives an Approval from FDA to Initiate Clinical Trials for its Anti-CD47 Monoclonal Antibody IBI-188 Read more
Dova Pharmaceuticals and Salix Enter Into Exclusive Co-Promotion Agreement For DOPTELET (Avatrombopag) Read more
Selexis SA and Hoba Therapeutics Team Up to Advance Hoba’s Investigational Neuropathic Pain Treatment into the Clinic Read more